ChengDa Pharmaceuticals Co. Ltd. (301201) — Free Cash Flow Generation Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Free Cash Flow Generation Index of -9.00x as of December 2024. Free cash flow of CN¥-257.72 Million represents -9% of operating cash flow (CN¥28.65 Million). See 301201 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. Explore how well can ChengDa Pharmaceuticals Co. Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for ChengDa Pharmaceuticals Co. Ltd.. For the full company profile including market capitalisation, see ChengDa Pharmaceuticals Co. Ltd. market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -9.00x | CN¥-257.72 Million | CN¥28.65 Million | CN¥286.36 Million | ▼ -5200.6% |
| 2023 | -0.17x | CN¥-32.60 Million | CN¥192.07 Million | CN¥224.67 Million | ▲ +94.9% |
| 2022 | -3.32x | CN¥-158.03 Million | CN¥47.67 Million | CN¥205.69 Million | ▼ -396.1% |
| 2021 | -0.67x | CN¥-55.56 Million | CN¥83.14 Million | CN¥138.70 Million | ▼ -232.3% |
| 2020 | 0.51x | CN¥65.16 Million | CN¥128.97 Million | CN¥63.81 Million | ▲ +107.2% |
| 2019 | 0.24x | CN¥16.46 Million | CN¥67.52 Million | CN¥51.06 Million | — |